Novel Drug Approvals for 2016

No. Drug Name Active Ingredient Approval Date FDA-approved use on approval date 22. Spinraza nusinersen 12/23/2016 To treat children and adults with spinal muscular atrophy (SMA) Press Release Drug Trials Snapshot 21. Rubraca rucaparib 12/19/2016 To treat women with a